Here is a comprehensive explanation of anemia with both classification systems:
Anemia — Definition & Classification
Definition
Anemia is defined as blood counts (hemoglobin/hematocrit/RBC count) below normal for a given population. Standard WHO thresholds: Hb < 13 g/dL in adult males, < 12 g/dL in adult females, < 11 g/dL in pregnant women.
(Harrison's Principles of Internal Medicine 22E, p. 492)
Two Major Classification Systems
There are two general approaches to classifying anemia, each with distinct clinical utility:
| Approach | Based on | Best use |
|---|
| Morphological | Red cell size (MCV) | Initial workup, guides differential |
| Etiological/Pathophysiological | Underlying mechanism | Definitive diagnosis, treatment planning |
I. MORPHOLOGICAL CLASSIFICATION (by MCV)
Pioneered by hematologist Max Wintrobe. Groups anemia by mean corpuscular volume (MCV). Less hemoglobin → smaller red cells; thus morphology reflects the synthesis defect.
A. Microcytic Anemia (MCV < 80 fL)
Caused by any process that interferes with hemoglobin production. All four causes affect either heme synthesis or globin synthesis:
| Cause | Mechanism | Key Features |
|---|
| Iron Deficiency Anemia | Insufficient iron → impaired heme synthesis | Most common worldwide; ↑TIBC, ↓ferritin, ↓serum iron |
| Thalassemia | Defective globin chain synthesis (α or β) | ↑RBC count, targeting on smear, abnormal Hb electrophoresis |
| Anemia of Chronic Disease | Cytokine-mediated iron sequestration (hepcidin↑) | Often normocytic; ↓TIBC, ↑ferritin |
| Sideroblastic Anemia | Defects of heme synthesis (pyridoxine pathway) | Ring sideroblasts on bone marrow; ↑serum iron, ↑ferritin |
| Lead Poisoning | Inhibits δ-aminolevulinic acid dehydratase | Basophilic stippling; ↑erythrocyte protoporphyrin |
(Goldman-Cecil Medicine, Table 144-9)
Differential diagnosis of microcytic anemia by lab:
B. Normocytic Anemia (MCV 80–100 fL)
This is the broadest category — a drawback of the morphological scheme. It includes all anemias where RBC production fails without a size change:
| Cause | Notes |
|---|
| Aplastic anemia | Marrow failure; pancytopenia |
| Anemia of chronic kidney disease | ↓Erythropoietin production |
| Anemia of inflammation (most cases) | Cytokine-mediated; normocytic in majority |
| Endocrinopathies | Hypothyroidism, adrenal insufficiency, androgen deficiency |
| Marrow invasion/infiltration | Leukemia, myeloma, myelofibrosis |
| Pure red cell aplasia | Selective erythroid suppression |
| Early iron deficiency | Before cells become microcytic |
| Sickle cell disease | Normocytic with sickle forms on smear |
| Physiologic anemia of pregnancy | Dilutional |
C. Macrocytic Anemia (MCV > 100 fL)
Due to defects in DNA synthesis (leading to oval macrocytes) or membrane/metabolic defects (leading to round macrocytes):
Megaloblastic (Oval Macrocytes) — impaired DNA synthesis:
- Vitamin B₁₂ deficiency (pernicious anemia, dietary)
- Folate deficiency
- Medications (methotrexate, hydroxyurea, certain anticonvulsants)
- Myelodysplastic syndrome (MDS)
Non-Megaloblastic (Round Macrocytes) — membrane defects/other:
- Alcohol use disorder (most common cause of macrocytosis)
- Liver disease
- Hypothyroidism
- Reticulocytosis (young RBCs are large)
- Dysproteinemia / hyperlipidemia
- Smoking, hypoxia
(Harrison's Principles of Internal Medicine 22E, p. 492)
II. ETIOLOGICAL / PATHOPHYSIOLOGICAL CLASSIFICATION
Based on the underlying mechanism. The reticulocyte count is the critical first step — it separates hypoproliferative (low retic) from hyperproliferative (high retic) causes.
A. BLOOD LOSS
| Type | Examples |
|---|
| Acute | Trauma, surgery, GI bleed, rupture |
| Chronic | GI tract lesions (ulcer, carcinoma), gynecologic (menorrhagia), hookworm |
Chronic blood loss eventually leads to iron deficiency.
B. INCREASED RBC DESTRUCTION (Hemolytic Anemias)
Characterized by ↑reticulocyte count, ↑LDH, ↑indirect bilirubin, ↓haptoglobin. Subdivided into intrinsic (inherited/acquired defect within the RBC) vs. extrinsic (external destructive forces):
1. Intrinsic (Intracorpuscular) Defects
a) Red Cell Membrane Disorders
- Hereditary Spherocytosis — mutations in ankyrin, band 3, spectrin, or band 4.2; spherocytes trapped in spleen; splenectomy is curative
- Hereditary Elliptocytosis — spectrin dimer self-association defects
b) Enzyme Deficiencies
- Hexose Monophosphate Shunt: G6PD deficiency (most common; X-linked; episodic hemolysis with oxidant stress), Glutathione synthetase deficiency
- Glycolytic Pathway: Pyruvate kinase (PK) deficiency, Hexokinase deficiency
c) Hemoglobin Abnormalities
- Deficient globin synthesis: Thalassemia syndromes (α and β)
- Structurally abnormal globins (Hemoglobinopathies): Sickle cell disease (HbS), unstable hemoglobins
d) Acquired Intracorpuscular Defect
- Paroxysmal Nocturnal Hemoglobinuria (PNH) — somatic mutation in PIG-A gene → deficiency of GPI-anchored complement regulatory proteins (CD55, CD59) → complement-mediated hemolysis
2. Extrinsic (Extracorpuscular) Defects
a) Immune-Mediated Destruction
- Autoimmune hemolytic anemia (AIHA): warm (IgG, spleen-mediated) and cold (IgM, complement-mediated)
- Hemolytic disease of the newborn (Rh/ABO incompatibility)
- Transfusion reactions
- Drug-induced (hapten, immune complex, or autoantibody mechanisms)
b) Mechanical Trauma
- Microangiopathic hemolytic anemias (MAHA): HUS, TTP, DIC — fibrin strands shear RBCs → schistocytes on smear
- Cardiac traumatic hemolysis: Defective prosthetic valves
- March hemoglobinuria: Repetitive physical trauma (marathon running, karate)
c) Infections of Red Cells
- Malaria (Plasmodium species invade and destroy RBCs)
- Babesiosis
d) Toxic/Chemical Injury
- Oxidant drugs, snake venoms, clostridial toxins, arsenic
e) Sequestration
- Hypersplenism (pooling and destruction in enlarged spleen)
C. DECREASED RBC PRODUCTION (Hypoproliferative/Maturation Defects)
Reticulocyte count is low (inappropriately for degree of anemia).
1. Nutritional Deficiencies
| Deficiency | Effect | Result |
|---|
| Iron | Impaired heme synthesis | Microcytic hypochromic anemia |
| Vitamin B₁₂ | Impaired DNA synthesis | Megaloblastic macrocytic anemia |
| Folate | Impaired DNA synthesis | Megaloblastic macrocytic anemia |
| Copper | Myelopathy + anemia | Normocytic or macrocytic |
2. Erythropoietin (EPO) Deficiency
- Chronic kidney disease — most important cause; loss of peritubular EPO-producing cells
- Anemia of endocrine deficiency (hypothyroidism, adrenal insufficiency)
3. Bone Marrow Failure / Stem Cell Defects
- Aplastic anemia — immune-mediated destruction of hematopoietic stem cells; pancytopenia; can be congenital (Fanconi anemia, telomerase defects) or acquired
- Pure red cell aplasia (PRCA) — selective suppression of erythroid progenitors (parvovirus B19, thymoma, autoimmune)
- Diamond-Blackfan syndrome — congenital PRCA
4. Marrow Infiltration / Replacement
- Leukemia, lymphoma, multiple myeloma
- Myelofibrosis
- Metastatic carcinoma
- Granulomatous disease (TB, sarcoid)
5. Inflammation-Mediated Iron Sequestration
- Anemia of chronic disease/inflammation — hepcidin ↑ → ferroportin degradation → iron trapped in macrophages → unavailable for erythropoiesis
6. Primary Hematopoietic Neoplasms
- Myelodysplastic syndrome (MDS) — dysplastic erythropoiesis, ineffective hematopoiesis
(Robbins, Cotran & Kumar — Pathologic Basis of Disease, Table 14.1; Harrison's 22E)
Summary Comparison Table
| Feature | Morphological | Etiological |
|---|
| Basis | MCV (red cell size) | Mechanism / pathophysiology |
| Categories | Microcytic / Normocytic / Macrocytic | Blood loss / Hemolysis / Decreased production |
| Clinical utility | Guides initial workup rapidly | Directs definitive treatment |
| Key tool | MCV on CBC | Reticulocyte count + peripheral smear |
| Limitation | Normocytic group is very broad | Requires more tests to classify |
Key takeaway: In clinical practice, both systems are used together. The MCV gives an immediate morphological direction; the reticulocyte count then separates the etiological mechanism. The peripheral blood smear integrates both — it confirms RBC size/shape and hints at the underlying cause (spherocytes → HS or AIHA; schistocytes → MAHA; hypersegmented neutrophils → megaloblastic; target cells → thalassemia or liver disease).